Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00132691 · ClinicalTrials.gov registry record · Phase 4
Multicenter Uveitis Steroid Treatment (MUST) Trial
A Phase 4 study, sponsored by JHSPH Center for Clinical Trials.
- Completed
- Registry status
- Phase 4
- Development phase
- 255
- Enrollment target
NCT00132691 is a Phase 4 study that has completed, run by JHSPH Center for Clinical Trials. The registered enrollment target is 255 participants.
The verdict
NCT00132691, a Phase 4 study, has completed, sponsored by JHSPH Center for Clinical Trials.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 255 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of standardized systemic therapy versus fluocinolone acetonide implant therapy for the treatment of severe cases of non-infectious intermediate uveitis, posterior uveitis, or panuveitis.
Interventions
- DRUG fluocinolone acetonide intraocular implant
- DRUG oral corticosteroid with immunosuppressive agents as needed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2005-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00132691
The ClinicalTrials.gov registry entry for NCT00132691 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is JHSPH Center for Clinical Trials, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fluocinolone acetonide intraocular implant is the first listed.
NCT00132691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00132691 about?
NCT00132691 is a clinical study titled "Multicenter Uveitis Steroid Treatment (MUST) Trial". The purpose of this study is to compare the effectiveness of standardized systemic therapy versus fluocinolone acetonide implant therapy for the treatment of severe cases of non-infectious intermediate uveitis, posterior uveitis, or panuveitis.
What is the current status of trial NCT00132691?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 255 participants. The study started on 2005-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00132691?
The interventions under investigation include: fluocinolone acetonide intraocular implant (DRUG), oral corticosteroid with immunosuppressive agents as needed (DRUG).
Who is sponsoring clinical trial NCT00132691?
This trial is sponsored by JHSPH Center for Clinical Trials, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.